1H and 13C NMR spectral assignments of halogenated transformation products
The structures of the chlorinated analogs of bisphenol A
References
were also determined (Table 6). The first chlorination occurred
at the C-5 position of the parent compound. The H-6 resonance
has a doublet of doublets coupling pattern in bisphenol A, but
in the monochlorinated bisphenol A, analog H-6 shows only a
pattern of long-range doublet coupling (J = 2.24 Hz). Also, the
downfield shift of C-5 from 115.5 ppm in the parent bisphenol
A to 120.9 ppm indicates a chloro substituent at C-5 position.
Similarly, this roughly 5 ppm downfield shift of the 13C
resonances of the chlorinated carbons was also observed in
di-, tri- and tetrachlorinated analogs of bisphenol A.
[1] D. W. Kolpin, E. T. Furlong, M. T. Meyer, E. M. Thurman, S. D.
Zauqq, L. B. Barber, H. T. Buxton. Environ. Sci. Technol. 2002,
36, 1202–1211.
[2] K. Fent, A. A. Weston, D. Caminada. Aquat. Toxicol. 2006,
76, 122–159.
[3] J. B. Quintana, R. Rodil, P. Lopez-Mahia, S. Muniategui-Lorenzo, D.
Prada-Rodriguez. Water Res. 2010, 44, 243–255.
[4] P. Canosa, S. Morales, I. Rodriguez, E. Rubi, R. Cela, M. Gomez. Anal.
Bioanal. Chem. 2005, 383, 1119–1126.
[5] R. M. Bean, R. G. Riley, Investigation of Halogenated Components
Formed from Chlorination of Natural Waters: Preliminary Studies,
The Commission, Washington, D.C., 1980.
In this work, the regiochemistry of halogenation of a wide
range of PPCPs was carried out using a combination of 1H survey
and 2D [1H,13C] HMBC experiments. The 1H and 13C chemical
shifts and coupling constants as well as the HMBC 13C-1H correla-
tions were used to elucidate the structures and unambiguously
determine the substitution locations. All compounds were
>97% pure except for four of the halogenated salicylic acid
analogs, which were difficult to completely resolve during their
reverse phase HPLC-UV isolation because of their similar
chromatographic behavior. Because of the chemical complexity
of environmental samples and the low levels at which
halogenated pharmaceuticals are found, they are typically
quantified using LC-MS methods, which require authentic
standards to verify chromatographic retention times and mass
spectral fragmentation patterns or MSn transitions. As most of the
halogenated compounds described in this work are not
commercially available, the reported resonance assignments can
be used to confirm the identity of halogenated analytical standards
prepared from the parent pharmaceuticals, as described herein.
[6] U. Dhagat, V. Carbone, R. P. Chung, T. Matsunaga, S. Endo, A. Hara, O.
El Kabbani. Med. Chem. 2007, 3, 546–550.
[7] H. N. Hong, H. N. Kim, K. S. Park, S.-K. Lee, M. B. Gu, Chemosphere
2007, 67, 2115–2121.
[8] D. N. Bulloch, R. Lavado, K. L. Forsgren, S. Beni, D. Schlenk, C. K.
Larive. Environ. Sci. Technol. 2012, 46, 5583–5589.
[9] K. Jeong-Hun, D. Aasi, Y. Katayama. Crit. Rev. Toxicol. 2007,
37, 607–625.
[10] H. Fukazawa, M. Watanabe, F. Shiraishi, H. Shiraishi, T. Shiozawa, H.
Matsushita, Y. Terao. J. Health Sci. 2002, 48, 242–249.
[11] A. Riu, M. Grimaldi, A. le Maire, G. Bey, K. Phillips, A. Boulahtouf, E.
Perdu, D. Zalko, W. Bourguet, P. Balaguer. Environ. Health Perspect.
2011, 119, 1227–1232.
[12] S. Jobling, J. P. Sumpter. Aquat. Toxicol. 1993, 27, 361–372.
[13] S. N. Pedersen, L. B. Christiansen, K. L. Pedersen, B. Korsgaard, P.
Bjerregaard. Sci. Total Environ. 1999, 233, 89–96.
[14] E. M. Thurman. J. Mass Spectrom. 2006, 41, 1287–1297.
[15] A. Bax, M. F. Summers. J. Am. Chem. Soc. 1986, 108, 2093–2094.
[16] W. H. Krkosek, S. A. Koziar, R. L. White, G. A. Gagnon. Water Res. 2011,
45, 1414–1422.
[17] S. Eğe, Organic Chemistry: Structure and Reactivity, Houghton Mifflin
Company, Boston, 2004.
Magn. Reson. Chem. 2014, 52, 310–317
Copyright © 2014 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/mrc